BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2 AND Treatment
6 results:

  • 1. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
    Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
    Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic variants and risk of thyroid cancer among Iranian patients.
    Jamshidi M; Farnoosh G; Mohammadi Pour S; Rafiee F; Saeedi Boroujeni A; Mahmoudian-Sani MR
    Horm Mol Biol Clin Investig; 2021 Feb; 42(2):223-234. PubMed ID: 33544997
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
    You L; Wang H; Yang G; Zhao F; Zhang J; Liu Z; Zhang T; Liang Z; Liu C; Zhao Y
    Mol Oncol; 2018 Dec; 12(12):2147-2164. PubMed ID: 30341811
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.
    Rupaimoole R; Ivan C; Yang D; Gharpure KM; Wu SY; Pecot CV; Previs RA; Nagaraja AS; Armaiz-Pena GN; McGuire M; Pradeep S; Mangala LS; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Zhang W; Lopez-Berestein G; Calin GA; Sood AK
    Oncogene; 2016 Aug; 35(33):4312-20. PubMed ID: 26725326
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Application of microRNA in diagnosis and treatment of ovarian cancer.
    Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Nogami Y; Umene K; Masuda K; Kisu I; Nomura H; Kataoka F; Tominaga E; Aoki D
    Biomed Res Int; 2014; 2014():232817. PubMed ID: 24822185
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation.
    Puppin C; Durante C; Sponziello M; Verrienti A; Pecce V; Lavarone E; Baldan F; Campese AF; Boichard A; Lacroix L; Russo D; Filetti S; Damante G
    Endocrine; 2014 Nov; 47(2):528-36. PubMed ID: 24569963
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.